Jafron

Established in 2002, Jafron is a global provider of technology, products, and therapy services in the hemoadsorption industry. With more than 20 years of clinical experience, Jafron's products provide support in areas including critical care, nephrology, hepatology, and immunological diseases. Jafron's hemoperfusion treatments are currently adopted by over 8,000 hospitals across 99 countries and regions, with more than 6,000,000 cases of clinical application annually.

Listed on ChiNext in 2016, Jafron is now one of the leading enterprises in the global blood purification industry. As a comprehensive adsorption solution provider, Jafron will continue to explore and innovate to excute its corporate mission -- "HEALTH TECHNOLOGY FOR A BETTER WORLD"!